Hilltelligence markHilltelligence
Archived This bill is from the 118th Congress (2023–2024) and is no longer under active consideration.
Bills/S. 1522118th Congress

A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable.

Senate: Referred
Cosponsors
0
Introduced
2023-05-10
Last action
2023-05-10

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sign in to view Hilltelligence’s plain-English summary.

Action Timeline
  1. SenateLatest

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  2. Senate

    Introduced in Senate

Sign in to view Hilltelligence’s passage-probability analysis.

Official Sources
Topics

Policy area

Health

Sign in to view Hilltelligence’s potential-cosponsor analysis.